News Quantified

LLY – eli lilly and company (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Eli Lilly and Company (LLY) is now covered by Royal Bank Of Canada. They set an "outperform" rating on the stock.

Novo downgraded at J.P. Morgan as next-gen obesity drug trails Lilly's Zepbound [Seeking Alpha]

Analysis-Novo's stumbles burnish Lilly's widening lead in weight-loss drugs [Yahoo! Finance Canada]

Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen [MSNBC.com]

Eli Lilly launches new form of obesity drug Zepbound with a month's worth of doses in one pen [CNBC]

2.9%

BEAT

-1.0%

BEAT

-1.6%

BEAT

-7.9%

MISS

Royal Bank Of Canada

Royal Bank Of Canada

Form 4 ELI LILLY & Co For: Feb 19 Filed by: Dozier Eric

Form 4 ELI LILLY & Co For: Feb 17 Filed by: Sulzberger Gabrielle

Form 4 ELI LILLY & Co For: Feb 17 Filed by: LUCIANO JUAN R

Form 4 ELI LILLY & Co For: Feb 17 Filed by: Fyrwald J Erik

Form 4 ELI LILLY & Co For: Feb 17 Filed by: Alvarez Ralph

Top News Gainers

3/12 Eli Lilly, AbCellera Biologics to co-develop coronavirus therapies [Reuters] 14.2%

3/2 U.S. FDA Accepts Regulatory Submission for Tanezumab, a Potential First-in-Class Treatment for Patients with Chronic Pain Due to Moderate-to-Severe Osteoarthritis 5.8%

4/13 Despite Qualms, Arthritis Drug to Be Tested in Coronavirus Study [The New York Times] 4.6%

4/2 Eli Lilly And Co (NYSE: LLY) had its price target lowered by analysts at Morgan Stanley from $150.00 to $148.00. They now have an "overweight" rating on the stock. 4.2%

3/23 FDA enacts abbreviated approval pathway for insulin biosimilars [Seeking Alpha] 3.2%

4/16 Lower-priced versions of Humalog® Mix75/25™ KwikPen® and Humalog® Junior KwikPen® now available 3.2%

10/28 Insider Buying: The Eli Lilly and Company (NYSE:LLY) Chairman Just Bought US$500k Worth Of Shares [Yahoo! Finance News] 2.7%

2/4 Form 4 ELI LILLY & Co For: Feb 01 Filed by: Zulueta Alfonso G 2.7%

12/18 Lilly Announces the Launch of TRIUMPH, the First, Long-Term, Real-World Evidence Study of Emgality® (galcanezumab-gnlm) 2.7%

3/23 Lilly Provides Update on Clinical Trial Activities During COVID-19 Pandemic 2.6%

Top News Decliners

3/11 Eli Lilly to Participate in Program to Make Insulin Cheaper for Seniors [The Motley Fool] -10.0%

3/18 Hap Sneddon's Top Picks: March 18, 2020 [Business News Network (BNN) Energy & Resources (Canada)] -7.6%

3/20 Form DEFA14A ELI LILLY & Co -5.8%

7/11 New England Journal of Medicine Publishes Positive Phase 3 Data for Emgality® (galcanezumab-gnlm) in Episodic Cluster Headache -5.3%

6/9 Lilly's ultra rapid lispro provided similar A1C reductions compared to Humalog® (insulin lispro), with superior post-meal blood glucose reductions -4.0%

8/14 Lilly Launches Open Innovation Challenge to Help Transform Inflammatory Bowel Disease (IBD) Care through Digital Health -4.0%

4/28 Form 8-K ELI LILLY & Co For: Apr 24 -3.5%

2/27 Local Organization NOVA ScriptsCentral Benefits BIG with Eli Lilly release of Bulk Donation Insulin Pens -3.4%

2/21 Trulicity® (dulaglutide) is the first and only type 2 diabetes medicine approved to reduce cardiovascular events in adults with and without established cardiovascular disease -3.4%

8/5 Lilly Announces Positive Results for Emgality® (galcanezumab-gnlm) from the CONQUER Study in Patients who Failed Previous Migraine Preventive Treatments -3.4%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day